You are here
Arizeke Pharmaceuticals, Inc.
UEI: N/A
# of Employees: N/A
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Quantitation Pulmonary Delivery of Therapeutic Protein
Amount: $251,779.00DESCRIPTION (provided by applicant): Arizeke Pharmaceuticals, Inc. is focused on the pulmonary delivery of protein therapeutics (including antibodies) to treat pulmonary disease. Arizeke's technology ...
STTRPhase I2005Department of Health and Human Services National Institutes of Health -
Quantitation Pulmonary Delivery of Therapeutic Protein
Amount: $251,779.00DESCRIPTION (provided by applicant): Arizeke Pharmaceuticals, Inc. is focused on the pulmonary delivery of protein therapeutics (including antibodies) to treat pulmonary disease. Arizeke's technology ...
SBIRPhase I2005Department of Health and Human Services National Institutes of Health -
Novel Aerosol Delivery System for Proteins
Amount: $107,000.00DESCRIPTION (provided by applicant): Because proteins and large macromolecular drugs do not normally cross epithelial barriers (i.e., intestine and lung), they are parenterally administered to patient ...
SBIRPhase I2003Department of Health and Human Services National Institutes of Health -
Affinity Maturation and Transcytosis
Amount: $106,307.00DESCRIPTION (provided by applicant): We have discovered a new method for administering proteins to the pulmonary system by a noninvasive technique using a receptor-mediated process. Because injection ...
SBIRPhase I2003Department of Health and Human Services National Institutes of Health